Patents by Inventor Lawrence Berlowitz Tarrant

Lawrence Berlowitz Tarrant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6605117
    Abstract: Disclosed is an osteogenic device capable of inducing the formation of endochondral bone in a shape conforming substantially to the shape of the device when implanted in a mammalian host. The device includes an osteogenic protein dispersed within a porous matrix comprising a polymer of collagen and glycosaminoglycan cross-linked to an MC value of about 800 to about 60,000. Also disclosed are a method of inducing mammalian bone growth, and a method of inducing conductive bone growth from viable mammalian bone.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: August 12, 2003
    Assignee: Stryker Corporation
    Inventors: Thangavel Kuberasampath, Lawrence Berlowitz Tarrant
  • Patent number: 6468308
    Abstract: Disclosed is an osteogenic device capable of inducing the formation of endochondral bone in a shape conforming substantially to the shape of the device when implanted in a mammalian host. The device includes an osteogenic protein dispersed within a porous matrix comprising a polymer of collagen and glycosaminoglycan cross-linked to an MC value of about 800 to about 60,000. Also disclosed are a method of inducing mammalian bone growth, and a method of inducing conductive bone growth from viable mammalian bone.
    Type: Grant
    Filed: June 25, 1998
    Date of Patent: October 22, 2002
    Assignee: Stryker Corporation
    Inventors: Thangavel Kuberasampath, Lawrence Berlowitz Tarrant
  • Publication number: 20020151985
    Abstract: Disclosed is an osteogenic device capable of inducing the formation of endochondral bone in a shape conforming substantially to the shape of the device when implanted in a mammalian host. The device includes an osteogenic protein dispersed within a porous matrix comprising a polymer of collagen and glycosaminoglycan cross-linked to an MC value of about 800 to about 60,000. Also disclosed are a method of inducing mammalian bone growth, and a method of inducing conductive bone growth from viable mammalian bone.
    Type: Application
    Filed: June 15, 2001
    Publication date: October 17, 2002
    Applicant: Stryker Corporation
    Inventors: Thangavel Kuberasampath, Lawrence Berlowitz Tarrant
  • Patent number: 6077988
    Abstract: Disclosed is an osteogenic device capable of inducing the formation of endochondral bone in a shape conforming substantially to the shape of the device when implanted in a mammalian host. The device includes an osteogenic protein dispersed within a porous matrix comprising a polymer of collagen and glycosaminoglycan cross-linked to an M.sub.c value of about 800 to about 60,000. Also disclosed are a method of inducing mammalian bone growth, and a method of inducing conductive bone growth from viable mammalian bone.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: June 20, 2000
    Assignee: Stryker Biotech Corporation
    Inventors: Thangavel Kuberasampath, Lawrence Berlowitz Tarrant
  • Patent number: 5645591
    Abstract: Disclosed is an osteogenic device capable of inducing the formation of endochondral bone in a shape conforming substantially to the shape of the device when implanted in a mammalian host. The device includes an osteogenic protein dispersed within a porous matrix comprising a polymer of collagen and glycosaminoglycan cross-linked to an M.sub.c value of about 800 to about 60,000. Also disclosed are a method of inducing mammalian bone growth, and a method of inducing conductive bone growth from viable mammalian bone.
    Type: Grant
    Filed: May 29, 1990
    Date of Patent: July 8, 1997
    Assignee: Stryker Corporation
    Inventors: Thangavel Kuberasampath, Lawrence Berlowitz Tarrant